Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy. (2018). Brazilian Journal of Pharmaceutical Sciences, 54(4), e17349. https://doi.org/10.1590/s2175-97902018000417349